XML 42 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2025
Net Loss Per Share [Abstract]  
Schedule of Anti-dilutive Shares

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30, 2025 and 2024 are as follows:

 

   Nine months
ended
September 30,
2025
(Shares)
   Nine months
ended
September 30, 
2024
(Shares)
 
Convertible debt   599,675,944    38,680,397 
Stock options   1,555,001    1,513,335 
Warrants to purchase shares of Common Stock   2,231,503,000    21,721,759 
    2,832,733,945    61,915,491